Given these limitations, we chose not to rely on BMI but instead adjusted for well-established clinical indicators of obesity, such as diabetes, hypertension, hyperlipidemia, insulin use, and the Charlson Comorbidity Index (CCI). This evidence concerns the gene INS and Hypertension.